BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹228 Cr | ₹93 Cr | ₹65 Cr | ₹48 Cr | ₹35 Cr |
What is the latest Net Current Assets ratio of BETA DRUGS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹228 Cr |
| Mar2024 | ₹93 Cr |
| Mar2023 | ₹65 Cr |
| Mar2022 | ₹48 Cr |
| Mar2021 | ₹35 Cr |
How is Net Current Assets of BETA DRUGS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹228 Cr | 145.01 | |
| Mar2024 | ₹93 Cr | 44.12 | |
| Mar2023 | ₹65 Cr | 34.76 | |
| Mar2022 | ₹48 Cr | 38.13 | |
| Mar2021 | ₹35 Cr | - | |
Compare Net Current Assets of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,831.3 Cr | 1.9% | 12.8% | 50.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 1.9% |
12.8% |
50.1% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses